Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6952326 | 0.91 | ALDH1A1 (0.48) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6953591 | 0.88 | KDM4E (0.53) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL29350690 | 0.84 | NPC1 (0.51) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6953979 | 0.84 | NPC1 (0.51) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6957303 | 0.82 | KDM4E (0.50) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6963817 | 0.79 | KDM4E (0.51) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL8683561 | 0.78 | KDM4E (0.67) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6955550 | 0.77 | KDM4E (0.49) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6954939 | 0.76 | KDM4E (0.65) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6961594 | 0.76 | RAB9A (0.54) | KDM4ELMNASMN1; SMN2MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540143-B1 | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 2003-02-05 | — | — | EP | disclosed |
| US-5714503-A | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 1998-02-03 | — | — | US | disclosed |
| US-5658907-A | THIOUREA VIRICIDES | MEDIVIR A/B (SE) | 1997-08-19 | — | — | US | disclosed |
| US-5593993-A | VIRICIDES FOR HTLV TREATMENT OF AIDS | MEDIVIR AB (SE) | 1997-01-14 | — | — | US | disclosed |
| EP-0540143-A2 | Compounds and methods for inhibition of HIV and related viruses | Medivir Aktiebolag (SE) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993003022-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1993-02-18 | — | — | WO | disclosed |